Pfizer to acquire sickle cell drugmaker GBT for $5 bn

‘Inside out’ signaling promotes tumor growth
8 August 2022
Australians with disabilities and their caregivers at more risk of homelessness, PTSD after floods
8 August 2022

Pfizer to acquire sickle cell drugmaker GBT for $5 bn

American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion.

Comments are closed.